Tropospheric ozone precursors: global and regional distributions, trends, and variability

Autor: Y. Elshorbany, J. R. Ziemke, S. Strode, H. Petetin, K. Miyazaki, I. De Smedt, K. Pickering, R. J. Seguel, H. Worden, T. Emmerichs, D. Taraborrelli, M. Cazorla, S. Fadnavis, R. R. Buchholz, B. Gaubert, N. Y. Rojas, T. Nogueira, T. Salameh, M. Huang

Publikováno v: Atmospheric Chemistry and Physics, Vol 24, Pp 12225-12257 (2024)

Tropospheric ozone results from in situ chemical formation and stratosphere–troposphere exchange (STE), with the latter being more important in the middle and upper troposphere than in the lower troposphere. Ozone photochemical formation is nonline

Externí odkaz: https://doaj.org/article/868dd0f280bd4cbc899a22d4a058c3cb

Evaluation of modelled versus observed non-methane volatile organic compounds at European Monitoring and Evaluation Programme sites in Europe

Autor: Y. Ge, S. Solberg, M. R. Heal, S. Reimann, W. van Caspel, B. Hellack, T. Salameh, D. Simpson

Publikováno v: Atmospheric Chemistry and Physics, Vol 24, Pp 7699-7729 (2024)

Atmospheric volatile organic compounds (VOCs) constitute a wide range of species, acting as precursors to ozone and aerosol formation. Atmospheric chemistry and transport models (CTMs) are crucial to understanding the emissions, distribution, and imp

Externí odkaz: https://doaj.org/article/4e00a1ab9a6645689459086f5b9e65da

Evaluation of Geospatial Climatic Variation and Aridity trend of the Jigawa State, Nigeria

Autor: V. T. Salam, Dr. A. Mahmood, Dr. A.T. Ogah, O. Mohammed

This study investigated evaluation of geospatial climatic variation and aridity increase, high risk zone with annual seasonal variation for a period of thirty years (30 years) from 1990 to 2020 in Jigawa State. Climatic data for this work are global

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8a64377d384b89ef81e7352130fc831

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators

Autor: Wojciech Zareba, James P. Daubert, Christopher A. Beck, David T. Huang, Jeffrey D. Alexis, Mary W. Brown, Kathryn Pyykkonen, Scott McNitt, David Oakes, Changyong Feng, Mehmet K. Aktas, Felix Ayala-Parades, Adrian Baranchuk, Marc Dubuc, Mark Haigney, Alexander Mazur, Craig A. McPherson, L. Brent Mitchell, Andrea Natale, Jonathan P. Piccini, Merritt Raitt, Mayer Y. Rashtian, Claudio Schuger, Stephen Winters, Seth J. Worley, Ohad Ziv, Arthur J. Moss, W. Zareba, K. Pyykkonen, A. Buttaccio, E. Perkins, D. DeGrey, S. Robertson, A.J. Moss, M. Brown, R. Lansing, A. Oberer, B. Polonsky, V. Ross, A. Papernov, S. Schleede, C. Beck, D. Oakes, C. Feng, S. McNitt S, W.J. Hall, A. Moss, J. Daubert, D. Huang, S. Winters, C. Schuger, M. Haigney, J. Piccini, J. Alexis, L. Chen, A. Miller, J.F. Richeson, S. Rosero, V. Kutyifa, A. Shah, G. Lamas, F. Cohn, F. Harrell, I. Piña, J. Poole, M. Sullivan, D. Lathrop, N. Geller, R. Boineau, J. Trondell, L. Cooper, E. Itturiaga, C. Gottlieb, S. Greer, C. Perzanowski, C. McPherson, C. Hedgepeth, C. Assal, T. Salam, I. Woollett, G. Tomassoni, F. Ayala-Paredes, A. Russo, S. Punnam, R. Sangrigoli, S. Sloan, S. Kutalek, A. Sun, D. Lustgarten, G. Monir, D. Haithcock, R. Sorrentino, D. Cannom, J. Kluger, S. Varanasi, M. Rashtian, F. Philippon, R. Berger, M. Mazzella, T. Lessmeier, J. Silver, S. Worley, M. Bernabei, D. Esberg, M. Dixon, P. LeLorier, Y. Greenberg, V. Essebag, G. Venkataraman, T. Shinn, M. Dubuc, G. Turitto, C. Henrikson, M. Mirro, M. Raitt, A. Baranchuk, G. O'Neill, E. Lockwood, M. Vloka, J. Hurwitz, R.H. Mead, P. Somasundarum, E. Aziz, E. Rashba, A. Budzikowski, M. Cox, A. Natale, E. Chung, O. Ziv, F. McGrew, K. Tamirisa, A. Greenspon, M. Estes, S. Taylor, R. Janardhanan, L.B. Mitchell, M. Burke, M. Attari, B. Mikaelian, S. Hsu, J. Conti, A. Mazur, S. Shorofsky, L. Rosenthal, S. Sakaguchi, D. Wolfe, G. Flaker, S. Saba, M. Aktas, P. Mason, A. Shalaby, D. Musat, R. Abraham, K. Ellenbogen, C. Fellows, N. Kavesh, G. Thomas, D. Hemsworth, B. Williamson

Publikováno v: Journal of the American College of Cardiology. 72:636-645

Background Ventricular tachycardia (VT) and ventricular fibrillation (VF) remain a challenging problem in patients with implantable cardioverter-defibrillators (ICDs). Objectives This study aimed to determine whether ranolazine administration decreas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6a3da108e14703d249a00ad70af08bb8
https://doi.org/10.1016/j.jacc.2018.04.086